View More Recent Stories

Oct 8, 2024 04:01PM Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
Sep 25, 2024 06:00AM Roth/MKM Reiterates Buy Rating on Cardiol Therapeutics (CRDL)
Sep 24, 2024 07:27AM Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis
Sep 10, 2024 07:29AM Cardiol Therapeutics (CRDL) Announces Completion of the MAvERIC Phase II Study
Sep 10, 2024 07:27AM Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
Jun 27, 2024 12:29PM Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
Jun 26, 2024 03:09AM Roth/MKM Starts Cardiol Therapeutics (CRDL) at Buy
Jun 25, 2024 07:27AM Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT
Jun 13, 2024 07:58AM Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
View More Recent Stories